Vera Therapeutics (VERA) Treasury Shares (2020 - 2021)

Vera Therapeutics (VERA) has 7 years of Treasury Shares data on file, last reported at $2.1 million in Q1 2026.

• Quarterly Treasury Shares rose 83.26% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 83.26% YoY) and the FY2025 annual result came in at $1.6 million, up 129.57% from the prior year.
• Treasury Shares grew to $2.1 million in Q1 2026, from $1.6 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.1 million in Q1 2026 to a low of $53860.0 in Q2 2022.
• A 5-year average of $654548.8 and a median of $472325.0 in 2024 frame the typical range for Treasury Shares.
• The widest YoY moves for Treasury Shares: up 5584.8% in 2022, down 99.97% in 2022.
• Tracing VERA's Treasury Shares over 5 years: stood at $204000.0 in 2022, then sank by 35.45% to $131679.0 in 2023, then surged by 429.23% to $696888.0 in 2024, then surged by 129.57% to $1.6 million in 2025, then jumped by 32.38% to $2.1 million in 2026.
• The last three Treasury Shares figures came in at $2.1 million (Q1 2026), $1.6 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.